Lu‐Zhe Sun

8.0k total citations
125 papers, 4.5k citations indexed

About

Lu‐Zhe Sun is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lu‐Zhe Sun has authored 125 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 57 papers in Oncology and 30 papers in Cancer Research. Recurrent topics in Lu‐Zhe Sun's work include TGF-β signaling in diseases (37 papers), Cancer Cells and Metastasis (26 papers) and Pancreatic and Hepatic Oncology Research (15 papers). Lu‐Zhe Sun is often cited by papers focused on TGF-β signaling in diseases (37 papers), Cancer Cells and Metastasis (26 papers) and Pancreatic and Hepatic Oncology Research (15 papers). Lu‐Zhe Sun collaborates with scholars based in United States, China and Canada. Lu‐Zhe Sun's co-authors include Abhik Bandyopadhyay, Junhua Yang, Michael G. Brattain, James K. V. Willson, Long Wang, Elizabeth Zborowska, Changguo Chen, I‐Tien Yeh, L E Gentry and Yuping Tang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Lu‐Zhe Sun

125 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu‐Zhe Sun United States 40 2.9k 1.7k 892 509 487 125 4.5k
Maréne Landström Sweden 32 3.2k 1.1× 1.3k 0.7× 1.0k 1.1× 587 1.2× 553 1.1× 81 4.7k
Sandra E. Dunn Canada 43 3.5k 1.2× 1.5k 0.9× 1.1k 1.2× 351 0.7× 391 0.8× 99 5.1k
Franca Stivala Italy 28 3.5k 1.2× 1.6k 0.9× 868 1.0× 653 1.3× 514 1.1× 58 5.4k
Pran K. Datta United States 32 2.6k 0.9× 1.3k 0.7× 851 1.0× 416 0.8× 316 0.6× 69 3.5k
Sophie Vacher France 39 2.6k 0.9× 1.5k 0.9× 1.5k 1.6× 331 0.7× 587 1.2× 142 4.5k
Claudio Festuccia Italy 45 2.8k 1.0× 1.6k 0.9× 1.1k 1.2× 313 0.6× 1.1k 2.3× 164 5.3k
Mickey C.‐T. Hu United States 33 3.2k 1.1× 1.3k 0.7× 923 1.0× 249 0.5× 543 1.1× 51 4.4k
Oliver Stoeltzing United States 43 3.0k 1.0× 1.6k 0.9× 1.4k 1.5× 312 0.6× 538 1.1× 73 4.6k
Remond J.A. Fijneman Netherlands 36 2.0k 0.7× 1.3k 0.8× 1.2k 1.3× 699 1.4× 556 1.1× 130 4.1k
Paweł Surowiak Poland 32 2.3k 0.8× 1.3k 0.7× 930 1.0× 283 0.6× 622 1.3× 97 3.7k

Countries citing papers authored by Lu‐Zhe Sun

Since Specialization
Citations

This map shows the geographic impact of Lu‐Zhe Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu‐Zhe Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu‐Zhe Sun more than expected).

Fields of papers citing papers by Lu‐Zhe Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu‐Zhe Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu‐Zhe Sun. The network helps show where Lu‐Zhe Sun may publish in the future.

Co-authorship network of co-authors of Lu‐Zhe Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Lu‐Zhe Sun. A scholar is included among the top collaborators of Lu‐Zhe Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu‐Zhe Sun. Lu‐Zhe Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yonghan, Chunbao Sun, Peiyi Zhang, et al.. (2025). A BCL-xL/BCL-2 PROTAC effectively clears senescent cells in the liver and reduces MASH-driven hepatocellular carcinoma in mice. Nature Aging. 5(3). 386–400. 10 indexed citations
2.
Xu, Yi, Zhenqing Ye, Naoki Akanuma, et al.. (2024). Reconstitution of human PDAC using primary cells reveals oncogenic transcriptomic features at tumor onset. Nature Communications. 15(1). 818–818. 7 indexed citations
3.
Lai, Zhao, Yidong Chen, Gangadhara R. Sareddy, et al.. (2024). PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma. Cancer Research Communications. 4(10). 2610–2620. 1 indexed citations
4.
Lin, Min, Jianan Zhang, Hakim Bouamar, et al.. (2022). Fbxo22 promotes cervical cancer progression via targeting p57Kip2 for ubiquitination and degradation. Cell Death and Disease. 13(9). 805–805. 17 indexed citations
5.
Shen, Qi, et al.. (2019). <p>Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas</p>. Drug Design Development and Therapy. Volume 13. 3161–3170. 12 indexed citations
6.
Zhou, Lulu, et al.. (2019). <p>Effects of dynein light chain Tctex-type 3 on the biological behavior of ovarian cancer</p>. Cancer Management and Research. Volume 11. 5925–5938. 8 indexed citations
7.
Chen, Guang, Hakim Bouamar, Bingzhi Wang, et al.. (2019). Everolimus Inhibits the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer Via Downregulation of MMP9 Expression. Clinical Cancer Research. 26(6). 1486–1496. 19 indexed citations
8.
Zhu, Haiyan, Xiang Gu, Lu Xia, et al.. (2018). A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers. Clinical Cancer Research. 24(12). 2780–2793. 54 indexed citations
9.
Shen, Qi, Xiaoli Hu, Lulu Zhou, et al.. (2018). Overexpression of the 14-3-3γ protein in uterine leiomyoma cells results in growth retardation and increased apoptosis. Cellular Signalling. 45. 43–53. 6 indexed citations
10.
Zhu, Haiyan, Lu Xia, Qi Shen, et al.. (2018). Differential effects of GLI2 and GLI3 in regulating cervical cancer malignancy in vitro and in vivo. Laboratory Investigation. 98(11). 1384–1396. 12 indexed citations
11.
Shen, Zhaojun, Saisai Li, Bo Sheng, et al.. (2018). The role of atorvastatin in suppressing tumor growth of uterine fibroids. Journal of Translational Medicine. 16(1). 53–53. 13 indexed citations
12.
Qin, Tai, James E. Schmitz, Roberto J. Fajardo, et al.. (2015). Estrogen and estrogen receptor alpha promotes malignancy and osteoblastic tumorigenesis in prostate cancer. Oncotarget. 6(42). 44388–44402. 50 indexed citations
13.
Gao, Hui, Abhik Bandyopadhyay, Anqi Wu, et al.. (2014). Pubertal Bisphenol A Exposure Alters Murine Mammary Stem Cell Function Leading to Early Neoplasia in Regenerated Glands. Cancer Prevention Research. 7(4). 445–455. 31 indexed citations
14.
Gowda, Pramod S., et al.. (2013). Inhibition of Hedgehog and Androgen Receptor Signaling Pathways Produced Synergistic Suppression of Castration-Resistant Prostate Cancer Progression. Molecular Cancer Research. 11(11). 1448–1461. 18 indexed citations
15.
Dong, Qiaoxiang, Abhik Bandyopadhyay, Hui Gao, et al.. (2013). Mammospheres from murine mammary stem cell-enriched basal cells: Clonal characteristics and repopulating potential. Stem Cell Research. 10(3). 396–404. 26 indexed citations
16.
Roy, Sudipa Saha, Dimple Chakravarty, Valerie Cortez, et al.. (2011). Significance of PELP1 in ER-Negative Breast Cancer Metastasis. Molecular Cancer Research. 10(1). 25–33. 36 indexed citations
17.
Sudarshan, Sunil, Karthigayan Shanmugasundaram, Susan L. Naylor, et al.. (2011). Reduced Expression of Fumarate Hydratase in Clear Cell Renal Cancer Mediates HIF-2α Accumulation and Promotes Migration and Invasion. PLoS ONE. 6(6). e21037–e21037. 44 indexed citations
18.
Scolan, Erwan Le, Qingwei Zhu, Long Wang, et al.. (2008). Transforming Growth Factor-β Suppresses the Ability of Ski to Inhibit Tumor Metastasis by Inducing Its Degradation. Cancer Research. 68(9). 3277–3285. 85 indexed citations
19.
Zhu, Qingwei, Ari Krakowski, Elizabeth E. Dunham, et al.. (2006). Dual Role of SnoN in Mammalian Tumorigenesis. Molecular and Cellular Biology. 27(1). 324–339. 82 indexed citations
20.
Wang, Jing, Wei Han, Elizabeth Zborowska, et al.. (1996). Reduced Expression of Transforming Growth Factor β Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma Cells. Journal of Biological Chemistry. 271(29). 17366–17371. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maréne Landström Breakdown of academic impact, for papers by Sandra E. Dunn Breakdown of academic impact, for papers by Franca Stivala Breakdown of academic impact, for papers by Pran K. Datta Breakdown of academic impact, for papers by Sophie Vacher Breakdown of academic impact, for papers by Claudio Festuccia Breakdown of academic impact, for papers by Mickey C.‐T. Hu Breakdown of academic impact, for papers by Oliver Stoeltzing Breakdown of academic impact, for papers by Remond J.A. Fijneman Breakdown of academic impact, for papers by Paweł Surowiak
Rankless by CCL
2026